Pharmacovigilance Europe Congress 2020 | Annual International Conference and Exhibition in Drug Safety, Regulatory Affairs, Risk Management and Clinical Tests

Conference Program

  • Home
  • Conference
  • Conference Program

19-20 May 2020 LONDON UK

Conference Program

image description

Registration & Refreshments

image description

Susan Welsh MD

Chief Safety Officer

Chair Person Opening Remarks

image description

Lana Gloukhova

Global Head of Regions

Pharmacovigilance Operation in Affiliates: Challenges, Solutions & Strategies

image description

​​​​​​​Kathy Willson 

PV Manager QA R&D

The Role of Regulatory Affairs in Pharmacovigilance

image description

Morning Refreshment Break & Networking

image description

Niraj Chhaya

Lead Risk Management,Global Pharmacovigilance

GVP IX - Updates related to Signal Management

image description

Jackie Roberts 

Executive Director - Regulatory,PHV and Medical

Brexit and the Impact on Pharmacovigilance

image description

Networking Luncheon

image description

Raj More

CEO & Chief Architect

Modern Technology Solutions to address Aggregate reporting and Data Analysis Challenges

  • Pharma Industry Technology Challenges
  • RxLogix PV Analytics Suite Overview
  • Review of Example Use Cases

 

Sponsored By

image description
image description

Stefan Rupp

Business Development Executive, Global Business Development

AUTOMATION

Sponsored By

image description
image description

​​​​​​​Sue Rees 

EU QPPV, Executive Director, Global Patient Safety

Role of PSUR'S in PV Inspections

image description

Afternoon Refreshment Break & Networking

image description

Stavros Kardahakis, PhD

Data Analysis & Proposals Specialist | Global Drug Safety & Pharmacovigilance

Challenges and Solutions in the New Era of Signal Detection

Sponsored By

image description
image description

Panel Discussion: PRAC Strategies to measure the Impact Factor of Pharmacovigilance

Panelists:

Mircea Ciuca, Global Medical Head - Vifor Pharma

Shelley Gandhi,Strategic Advisor - PV, NDA REG

Oleksandr Karpenko, Director, Olexacon

Nawab Qizilbash, Clinical Epidemiologist & Head, OXON

Moderator:

Susan Welsh, Chief Safety Officer, CSL Behring

image description

Susan Welsh MD

Chief Safety Officer

Chairperson’s Closing Remarks

image description

Networking Drinks Reception

image description

Registration & Refreshments

image description

Susan Welsh MD

Chief Safety Officer

Chair Person Opening Remarks

image description

Mircea Ciuca

Global Medical Head

Future of Pharmacovigilance

image description

Bert Van Leeuwen

Global Pharmacovigilance Department

Review of the new EU Legislation on Pharmacovigilance


 

image description

Morning Refreshment Break & Networking

image description

Dr Stephanie Millican

Unit Manager | MHRA

Pharmacovigilance & BREXIT

image description

Raj Bhogal

Safety & International Director, Global Quality

PV Audits & Inspections Inspections

image description

Andrew Bond

Associate Director, Pharmacovigilance Agreement CSL Behring | Australia

Overcome the Challenge of Managing PV Agreements Across the Enterprise and Between Third Parties

image description

Networking Luncheon

image description

Giovanni Furlan

Safety Risk Lead Director

Drug Safety in Elderly Patients - Current Status and Way Forward


 

image description

Alina Tudor

Associate Director

Outsourcing Pharmacovigilance Activities: How to set it right?

image description

Edita Kaupiene, MPharm

Pharmacovigilance Project Manager Biomapas

Remaining vigilant locally and globally: Current Challenges and Possible Solutions

Sponsored by

image description
image description

Afternoon Refreshment Break & Networking

image description

Nawab Qizilbash

Clinical Epidemiologist & Head, OXON

PASS Studies

image description

Panel Discussion & Speak Out Session - HOT Topics

  • Patient Support Programme
  • Medication Errors
  • Off Label Usage

Panelists:

Chetan Shatapathy, Principal Pharmacovigilance Physician - AstraZeneca Ltd.

Shelley Gandhi,Strategic Advisor - PV, NDA REG

Oleksandr Karpenko, Director, Olexacon

Mircea Ciuca, Global Head, Medical & Clinical Drug Safety, Vifor Pharma

Moderator:

Susan Welsh, Chief Safety Officer, CSL Behring

image description

Susan Welsh MD

Chief Safety Officer

Chairperson’s Closing Remarks & End of Conference